On Wednesday, Shares of American Airlines Group Inc. (NASDAQ:AAL), surged 5.89% to $41.51.
American Airlines Group Chief Financial Officer Derek Kerr will present at Cowen and Company’s 8th Annual Global Transportation Conference on Wednesday, September 9, at 8 a.m. EDT.
American Airlines Group Inc., through its auxiliaries, operates in the airline industry. As of December 31, 2014, the company operated 983 mainline jets, in addition to 566 regional aircrafts through regional airline auxiliaries and third-party regional carriers.
Shares of Great Basin Scientific, Inc. (NASDAQ:GBSN), declined -30% to $0.21, during its last trading session.
Great Basin Scientific declared that the Company has presented its Staph ID/R Blood Culture Panel to the U.S. Food & Drug Administration (FDA) for 510(k) clearance. The submission of the Staph ID/R panel, the Company’s first multiplex panel, comes after the successful completion of a clinical trial that met all of Great Basin’s clinical objectives. Great Basin offers the first and only molecular diagnostic platform capable of low-plex tests, in addition to multiplex and direct-from-specimen panels.
The Great Basin Staph ID/R Blood Culture Panel is a sample-to-result, automated, molecular multiplex panel that detects Staph aureus and two other staph species together with the mecA gene, a major drug resistance marker that confers resistance to methicillin and creates the superbug MRSA. In addition to Staph aureus, the panel also detects Staphylococcus lugdunensis and Staphylococcus epidermidis. The remaining staph species are detected as a group and identified as “Staphylococcus present.” When contrast to traditional blood culture methods, results of this panel are predictable to allow for a faster diagnosis and therefore a more timely appropriate therapy, which is associated with improved patient outcomes, lower treatment costs, and shorter length of hospital stay for affected patents.
Great Basin Scientific, Inc., a molecular diagnostic testing company, doing business as Great Basin Corporation, develops and commercializes molecular diagnostic systems that are designed to test hospital-attained infections.
Finally, Sysco Corporation (NYSE:SYY), ended its last trade with 1.77% gain, and closed at $39.77.
Sysco Corporation has updated its online sustainability report, providing information on the company’s economic, environmental and social responsibility performance. The report, titled “Delivering on Our Commitments,” outlines Sysco’s planned approach to sustainability in its three focus areas of food, operations, and community. Some notable highlights in the report comprise:
- Food - Our industry-leading Integrated Pest Administration Program has expanded to comprise standards that assist protect bee populations.
- Operations - Warehouse efficiency initiatives have generated energy savings of nearly 40 percent since the program’s inception in 2006.
- Community - Purchases from minority- and women-owned suppliers more than doubled in the past eight years, increasing from $400 million to $925 million.
Sysco Corporation, through its auxiliaries, markets and distributes a range of food and related products primarily to the foodservice or food-away-from-home industry. It distributes a line of frozen foods, such as meats, seafood, fully prepared entrees, fruits, vegetables, and desserts; a line of canned and dry foods; fresh meats and seafood; dairy products; beverage products; imported specialties; and fresh produce.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
